Interesting post Lolly.
There seem to be more and more articles acknowledging limitations with traditional staging.
Hopefully as gene array become more economic and accepted people will get treatments that are applicable to them rather than what appears in the past to be a blanket based approach.
It seems to me that this is particulary important for early diagnosis of younger fertile sufferers who have to make decisions on chemo treatments that impact on long fertility etc.
RB
|